Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes

BMC Genomics

Volumn 16, Issue 7, 2015, Pages

  Zhong, Xue ^a   Yang, Hushan ^b   Zhao, Shuyang ^c   Shyr, Yu ^a,d   Li, Bingshan ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Network based stratification; Networks; Subtyping; Tumor somatic mutations

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYSTADENOCARCINOMA; ENDOMETRIUM CARCINOMA; ESOPHAGEAL ADENOCARCINOMA; EXOME; FOUNDATIONONE; GENE CLUSTER; GENE NUMBER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; MELANOMA; MULTIPLE MYELOMA; MUTATION RATE; NETWORK BASED STRATIFICATION ANALYSIS; OVARY ADENOCARCINOMA; OVERALL SURVIVAL; PANCAN; SEQUENCE ANALYSIS; SOMATIC MUTATION; SQUAMOUS CELL LUNG CARCINOMA; TRANSITIONAL CELL CARCINOMA; TRUESEQ; TUMOR GENE; ALGORITHM; BIOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; MUTATION; NEOPLASM; ONCOGENE; PATHOLOGY; PROCEDURES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR GENE;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; EXOME; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; NEOPLASMS; ONCOGENES; SURVIVAL ANALYSIS;

EID: 84969271120     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-16-S7-S7     Document Type: Article

References (27)

1. Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474 (7353): 609-615. 10.1038/nature10166.
2. Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al: Integrated genomic characterization of endometrial carcinoma. Nature. 2013, 497 (7447): 67-73. 10.1038/nature12113.
3. Konstantinopoulos PA, Spentzos D, Cannistra SA: Gene-expression profiling in epithelial ovarian cancer. Nat Clin Pract Oncol. 2008, 5 (10): 577-587. 10.1038/ncponc1178.
4. Konstantinopoulos PA, Spentzos D, Karlan BY, Taniguchi T, Fountzilas E, et al: Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. J Clin Oncol. 2010, 28 (22): 3555-3561. 10.1200/JCO.2009.27.5719.
5. Reis-Filho JS, Pusztai L: Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011, 378 (9805): 1812-1823. 10.1016/S0140-6736(11)61539-0.
6. Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012, 487 (7407): 330-337. 10.1038/nature11252.
7. Chmielecki J, Pietanza MC, Aftab D, Shen R, Zhao Z, et al: EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib. J Thorac Oncol. 2012, 7 (2): 434-442. 10.1097/JTO.0b013e31823c5aee.
8. Olivier M, Taniere P: Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes. Curr Opin Oncol. 2011, 23 (1): 88-92. 10.1097/CCO.0b013e3283412dfa.
9. Pirazzoli V, Nebhan C, Song X, Wurtz A, Walther Z, Cai G, et al: Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. Cell Rep. 2014, 7 (4): 999-1008. 10.1016/j.celrep.2014.04.014.
10. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, et al: Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014, 505 (7484): 495-501. 10.1038/nature12912.
11. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko P, et al: Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013, 499 (7457): 214-218. 10.1038/nature12213.
12. Hofree M, Shen JP, Carter H, Gross A, Ideker T: Network-based stratification of tumor mutations. Nat Methods. 2013, 10 (11): 1108-1115. 10.1038/nmeth.2651.
13. Chuang HY, Lee E, Liu YT, Lee D, Ideker T: Network-based classification of breast cancer metastasis. Mol Syst Biol. 2007, 3: 140-
14. Ideker T, Sharan R: Protein networks in disease. Genome Res. 2008, 18 (4): 644-652. 10.1101/gr.071852.107.
15. Ciriello G, Cerami E, Sander C, Schultz N: Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 2012, 22 (2): 398-406. 10.1101/gr.125567.111.
16. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al: Mutational landscape and significance across 12 major cancer types. Nature. 2013, 502 (7471): 333-339. 10.1038/nature12634.
17. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144 (5): 646-674. 10.1016/j.cell.2011.02.013.
18. Kreeger PK, Lauffenburger DA: Cancer systems biology: a network modeling perspective. Carcinogenesis. 2010, 31 (1): 2-8. 10.1093/carcin/bgp261.
19. Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, et al: Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov. 2014, 4 (2): 232-245. 10.1158/2159-8290.CD-13-0286.
20. Frampton GM, Fichtenholtz A, Otto GA, Wang K, Downing SR, He J, et al: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013, 31 (11): 1023-1031. 10.1038/nbt.2696.
21. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW, et al: Cancer genome landscapes. Science. 2013, 339 (6127): 1546-1558. 10.1126/science.1235122.
22. Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, et al: Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin. Cell. 2014, 158 (4): 929-944. 10.1016/j.cell.2014.06.049.
23. Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM: Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res. 2011, 21 (7): 1109-1121. 10.1101/gr.118992.110.
24. Lee DD, Seung HS: Learning the parts of objects by non-negative matrix factorization. Nature. 1999, 401 (6755): 788-791. 10.1038/44565.
25. Cai DH X, Wu X, Han J: Non-negative Matrix Factorization on Manifold. IEEE. 2008, 63-72.
26. Stefano Monti PT, Mill Mesirov, Todd Golub: Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Machine Learning. 2003, 52: 91-118. 10.1023/A:1023949509487.
27. Brunet JP, Tamayo P, Golub TR, Mesirov JP: Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci USA. 2004, 101 (12): 4164-4169. 10.1073/pnas.0308531101.